Beth A. McCormick, PhD
Research Focus - Microbial-Based Cancer Therapy
- Advancing preclinical development of novel microbial-based anticancer therapeutic agents
- Investigating the interplay between microbes, tumors, and the immune system
- Developing next-generation microbial therapeutics for multidrug resistance
Representative Publication
Mercado-Lubo R, Zhang Y, Zhao L, et al. A Salmonella nanoparticle mimic overcomes multidrug resistance in tumors. Nat Commun. 2016;7:12225
In the News
Getting Results…
-
Education News, MediaRead more
-
Research News
New study of oral therapy candidate indicates positive results for patients with mild-to-moderate COVID-19
Read more -
Research News
Novel therapeutic, based on UMMS microbiome discoveries and licensed by Bacainn Therapeutics, targets ulcerative colitis
Read more